Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2144268

Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension

Author
PITTROW, D. B1 ; ANTLSPERGER, A2 ; WELZEL, D2 ; WAMBACH, G3 ; SCHARDT, W4 ; WEIDINGER, G1
[1] Department of Clinical Research, Novartis Pharma AG, Nürnberg, Germany
[2] Department of Pharmacology, University of Regensburg, United States
[3] Hospital Merheim, Cologne, Germany
[4] Department of Internal Medidne, University of Würzburg, Germany
Source

Cardiovascular drugs and therapy. 1997, Vol 11, Num 5, pp 619-627 ; ref : 29 ref

CODEN
CDTHET
ISSN
0920-3206
Scientific domain
Cardiology, blood circulation, phlebology; Pharmacology drugs
Publisher
Springer, Dordrecht
Publication country
Netherlands
Document type
Article
Language
English
Keyword (fr)
Antagoniste calcium Antihypertenseur Association médicamenteuse Chimiothérapie Dihydropyridine dérivé Dose faible Etude comparative Hypertension artérielle Inhibiteur angiotensin converting enzyme Isradipine Spirapril Traitement Appareil circulatoire pathologie
Keyword (en)
Calcium antagonist Antihypertensive agent Drug combination Chemotherapy Dihydropyridine derivatives Low dose Comparative study Hypertension ACE inhibitor Isradipine Spirapril Treatment Cardiovascular disease
Keyword (es)
Antagonista calcio Antihipertensivo Asociación medicamentosa Quimioterapia Dihidropiridine derivado Dosis débil Estudio comparativo Hipertensión arterial Inhibidor angiotensin converting enzyme Isradipino Espirapril Tratamiento Aparato circulatorio patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F05 Antihypertensive agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
2144268

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web